Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine.

× No keyword cloud information.

16 in total

1. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.

Authors: A M Gallon
Journal: Thorax Date: 1996-04 Impact factor: 9.139

2. Reduction of nonspecific fluorescence in respiratory specimens by pretreatment with N-acetylcysteine.

Authors: H R Miller; P H Phipps; E Rossier
Journal: J Clin Microbiol Date: 1986-09 Impact factor: 5.948

3. The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.

Authors: Jeanette Gaydos; Alicia McNally; Ellen L Burnham
Journal: Alcohol Date: 2018-09-05 Impact factor: 2.405

4. Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.

Authors: Fanuel T Hagos; Monica J Daood; Jacob A Ocque; Thomas D Nolin; Hulya Bayir; Samuel M Poloyac; Patrick M Kochanek; Robert S B Clark; Philip E Empey
Journal: Xenobiotica Date: 2016-06-09 Impact factor: 1.908

5. The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.

Authors: S W Clarke; M T Lopez-Vidriero; D Pavia; M L Thomson
Journal: Br J Clin Pharmacol Date: 1979-01 Impact factor: 4.335

6. Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?

Authors: E Hjortsø; J S Fomsgaard; N Fogh-Andersen
Journal: Eur J Clin Pharmacol Date: 1990 Impact factor: 2.953

Laboratory and clinical evaluation of the mucolytic properties of acetylcysteine.

1. Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy.

2. Reduction of nonspecific fluorescence in respiratory specimens by pretreatment with N-acetylcysteine.

3. The impact of alcohol use disorders on pulmonary immune cell inflammatory responses to Streptococcus pneumoniae.

4. Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.

5. The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis.

6. Does N-acetylcysteine increase the excretion of trace metals (calcium, magnesium, iron, zinc and copper) when given orally?

7. The promises and limitations of N-acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs.

8. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro.

9. Effect of the mucoregulator S-carboxy-methyl-cysteine in patients with chronic bronchitis.

10. N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.